Endometrial carcinoma: Systemic therapies. Part 2 - The nurses' perspective

Update: 2023-12-06

Description

Join Lead Nurse Andreia Fernandes and Clinical Nurse Specialist Jo Pearson as they explain how to help patients navigate the side effects of systemic therapies in endometrial carcinoma. Specialist nurses have a critical role helping women stay on treatment and at home for as long as possible. They discuss their privileged position supporting women with endometrial carcinoma and how they continue to educate and advocate for women in a fast-changing therapeutic environment.

Comments

In Channel

Advanced or recurrent endometrial cancer: Molecular classification and treatment decisions

2025-02-1711:28

Treatment of severe PPH – Learnings from clinical practice

2024-06-1723:31

Latest strategies for prevention and management of PPH (2)

2025-01-1334:56

Severe postpartum hemorrhage (PPH) series: Part 4

2024-02-2724:10

Latest strategies for prevention and management of PPH

2024-01-1734:56

IUD placement - reducing anxiety and pain

2023-12-0635:29

Severe PPH: Part 1 - Definitions and real-world incidence

2023-12-0625:45

Endometrial carcinoma: Systemic therapies. Part 2 - The nurses' perspective

2023-12-0628:03

Endometrial carcinoma: Systemic therapies. Part 1 - The physicians' perspective

2023-12-0629:25

Bleeding disorders in women: Gynecological considerations

2023-12-0619:18

Bleeding disorders in women: Why iron matters

2023-12-0622:02

Bleeding disorders in women: Pregnancy - What to expect when they're expecting

2023-12-0625:31

Severe PPH: Part 1 - Definitions and real-world incidence

2023-12-0425:45

00:00

Endometrial carcinoma: Systemic therapies. Part 2 - The nurses' perspective

#box-pro-ellipsis-175965075766581{-webkit-line-clamp:2;}Endometrial carcinoma: Systemic therapies. Part 2 - The nurses' perspective

Endometrial carcinoma: Systemic therapies. Part 2 - The nurses' perspective

COR2ED Medical Education

Endometrial carcinoma: Systemic therapies. Part 2 - The nurses' perspective